Search research articles
Contact Us
Filters
Showing results (251-260 of 296) with videos related to
Page
of 30
Sort By:
Kidney International
|
December 24, 2025
A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy
Sean J Barbour, Michelle A Hladunewich, Michael L McCaleb, et al.
Substance Abuse
|
February 22, 2022
Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in Pennsylvania
S Kawasaki, G Hwang, K Buckner, et al.
Kidney International Reports
|
April 30, 2025
Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts
Sean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Nature Communications
|
June 22, 2018
C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease
Antoine Dufour, Caroline L Bellac, Ulrich Eckhard, et al.
Kidney International Reports
|
July 18, 2025
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1283-1287]
Sean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Kidney International
|
May 29, 2020
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool
Sean J Barbour, Mark Canney, Rosanna Coppo, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 12, 2024
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
Jonathan Barratt, Adrian Liew, See Cheng Yeo, et al.
JAMA Internal Medicine
|
April 14, 2019
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Sean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Nature Chemistry
|
February 13, 2023
Reversible transformations between the non-porous phases of a flexible coordination network enabled by transient porosity
Varvara I Nikolayenko, Dominic C Castell, Debobroto Sensharma, et al.
Journal of the American Society of Nephrology : JASN
|
October 27, 2024
Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
Jonathan Barratt, Sean J Barbour, Robert M Brenner, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 296) with videos related to
Sort By:
Page
of 30
Kidney International
|
December 24, 2025
A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy
Sean J Barbour, Michelle A Hladunewich, Michael L McCaleb, et al.
Substance Abuse
|
February 22, 2022
Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in Pennsylvania
S Kawasaki, G Hwang, K Buckner, et al.
Kidney International Reports
|
April 30, 2025
Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts
Sean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Nature Communications
|
June 22, 2018
C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease
Antoine Dufour, Caroline L Bellac, Ulrich Eckhard, et al.
Kidney International Reports
|
July 18, 2025
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1283-1287]
Sean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Kidney International
|
May 29, 2020
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool
Sean J Barbour, Mark Canney, Rosanna Coppo, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 12, 2024
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
Jonathan Barratt, Adrian Liew, See Cheng Yeo, et al.
JAMA Internal Medicine
|
April 14, 2019
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Sean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Nature Chemistry
|
February 13, 2023
Reversible transformations between the non-porous phases of a flexible coordination network enabled by transient porosity
Varvara I Nikolayenko, Dominic C Castell, Debobroto Sensharma, et al.
Journal of the American Society of Nephrology : JASN
|
October 27, 2024
Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
Jonathan Barratt, Sean J Barbour, Robert M Brenner, et al.
Page
of 30